APA (7th ed.) Citation

Jr, C. J., 3rd, C. H., C, V. L., PR, G., & ME, A. (2023). Using available in vitro metabolite identification and time course kinetics for β-chloroprene and its metabolite, (1-chloroethenyl) oxirane, to include reactive oxidative metabolites and glutathione depletion in a PBPK model for β-chloroprene. Frontiers in pharmacology, 14, 1223808. https://doi.org/10.3389/fphar.2023.1223808

Chicago Style (17th ed.) Citation

Jr, Campbell JL, Clewell HJ 3rd, Van Landingham C, Gentry PR, and Andersen ME. "Using Available in Vitro Metabolite Identification and Time Course Kinetics for β-chloroprene and Its Metabolite, (1-chloroethenyl) Oxirane, to Include Reactive Oxidative Metabolites and Glutathione Depletion in a PBPK Model for β-chloroprene." Frontiers in Pharmacology 14 (2023): 1223808. https://doi.org/10.3389/fphar.2023.1223808.

MLA (9th ed.) Citation

Jr, Campbell JL, et al. "Using Available in Vitro Metabolite Identification and Time Course Kinetics for β-chloroprene and Its Metabolite, (1-chloroethenyl) Oxirane, to Include Reactive Oxidative Metabolites and Glutathione Depletion in a PBPK Model for β-chloroprene." Frontiers in Pharmacology, vol. 14, 2023, p. 1223808, https://doi.org/10.3389/fphar.2023.1223808.